Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
lopinavir-ritonavir
DRUG
2 trials
Sponsors
Frontier Biotechnologies Inc.
, University of Oxford
Conditions
AIDS
HIV Infections
Pneumonia
Phase 3
Test Albuvirtide in Experienced Patients
Completed
NCT02369965
Frontier Biotechnologies Inc.
AIDS, HIV Infections
Start: 2014-02-19
End: 2018-04-02
Updated: 2021-10-06
Randomised Evaluation of COVID-19 Therapy
Recruiting
NCT04381936
University of Oxford
Pneumonia
Start: 2020-03-19
End: 2038-09-30
Target: 70000
Updated: 2026-04-21
Related Papers
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
2025-08-28
2 citations
Molnupiravir or nirmatrelvir-ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
2025-05-15
1 citations
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
2025-02-12
4 citations
Clinical trial results in context: comparison of baseline characteristics and outcomes of 38,510 RECOVERY trial participants versus a reference population of 346,271 people hospitalised with COVID-19 in England
Trials
2024-06-29
4 citations
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
2024-01-31
7 citations
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.
2024-01-22
18 citations
Dapagliflozin in patients with critical illness: rationale and design of the DEFENDER study.
2023-12-22
2 citations
Cardiac assessment and inflammatory markers in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV2 (PIMS-TS) treated with methylprednisolone versus intravenous immunoglobulins: 6-month follow-up outcomes of the randomised controlled Swissped RECOVERY trial.
2023-12-06
5 citations
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
2023-10-18
23 citations
The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial.
2023-07-28
15 citations
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
2023-04-13
84 citations
Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial.
2023-02-03
31 citations
Challenges of using external data in clinical trials- an illustration in patients with COVID-19
BMC Medical Research Methodology
2022-12-15
4 citations
FRAGILE-COLCOVID19: A Clinical Trial Based on Early Administration of an Oral Combination of Colchicine and Prednisone in Elderly Patients with COVID-19 in Geriatric Facilities
Clinical Drug Investigation
2022-09-29
3 citations
Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study.
2022-09-22
11 citations
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
2022-07-01
233 citations
Multicenter Randomized Trial of Methylprednisolone vs. Intravenous Immunoglobulins to Treat the Pediatric Inflammatory Multisystem Syndrome-Temporally Associated With SARS-CoV-2 (PIMS-TS): Protocol of the Swissped RECOVERY Trial.
2022-05-20
10 citations
Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial
Trials
2022-04-27
3 citations
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
2022-02-01
340 citations
Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID‐19: Insights from the HOPE COVID‐19 Registry
International Journal of Clinical Practice
2022-01-01
5 citations
15 more papers not shown